Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06430840Not ApplicableActive Not Recruiting

Addressing Financial and Social Needs Among Patients With Cancer

Role: collaborator

NCT00540852Not ApplicableCompleted

Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy

Role: collaborator

NCT02244749Completed

Role of Metabolic Enzymes in Non-Melanoma Skin Cancer

Role: collaborator

NCT00513461Phase 2Completed

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Role: lead

All 4 trials loaded